Truist Financial upgraded shares of Caribou Biosciences, and MarketBeat provided average rating and price target.
1 report, 1 independent
Updated Jul 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial upgraded shares of Caribou Biosciences, and MarketBeat provided average rating and price target.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Caribou Biosciences
company in Berkeley, United States
Nothing else this week.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
-
MarketBeat
American personal finance blog
Related events
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
- Rapid Micro Biosystems and Thermo Fisher Scientific are competing in the life sciences/healthcare market, with MarketBeat providing analyst ratings and coverage.
- Truist Financial decreased its price target on Leggett & Platt.
- Truist Financial reissued a 'hold' rating and set a target price for Inspire Medical Systems.
- MarketBeat has released its consensus rating and target price for Sunshine Biopharma, Inc.